Literature DB >> 9732158

Prolactin: does it have a role in the pathogenesis of psoriasis?

A S Giasuddin1, A I El-Sherif, S I El-Ojali.   

Abstract

BACKGROUND: The aetiopathogenesis of psoriasis is still not fully understood. Recently, it has been reported that prolactin (PRL) exerts a proliferative effect on human keratinocytes in vitro. PRL may, therefore, play an important role in the pathogenesis of psoriasis.
OBJECTIVE: To assess the serum PRL level in patients with psoriasis vulgaris (PV).
METHODS: Serum levels of PRL were estimated in 12 patients with PV (age: 11-45 years with mean +/- SD 30.4 +/- 10.2 years; sex: 7 males, 5 females) and the results were compared with those in 9 patients with atopic dermatitis (age: 15-47 years with mean +/- SD 28.1 +/- 11.9 years; sex: 4 males, 5 females) and 20 normal control subjects (age: 16-45 years with mean +/- SD 36.1 +/- 11.9 years; sex: 15 males, 5 females).
RESULTS: Serum PRL in PV (mean +/- SD 25.8 +/- 16.1 ng/ml) was significantly higher compared to those in atopic dermatitis (mean +/- SD 9.1 +/- 4.7 ng/ml) and normal control subjects (mean +/- SD 10.3 +/- 5.3 ng/ml; ANOVA --> p = 0.0008). Three patients with PV (2 males and 1 female with ages of 35, 40 and 11 years, respectively) had the highest serum levels well above the normal range but they were <100 ng/ml, the minimum limit for the diagnosis of prolactinoma (chi2 test --> p <0.025).
CONCLUSION: Since PRL belongs to the growth hormone family, its raised serum level may have a role in the hyperproliferation of kerationocytes in vivo, the hallmark of the psoriasis disease process.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9732158     DOI: 10.1159/000017981

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  10 in total

1.  Serum prolactin levels in patients with psoriasis: Results of a pilot study.

Authors:  Gaytri Khatri; Vikram K Mahajan; Karaninder S Mehta; Krishan Kumar Sharma; Satya Bhushan; Pushpinder S Chauhan
Journal:  Indian J Med Res       Date:  2017-02       Impact factor: 2.375

2.  Polymorphism of the prolactin extrapituitary promoter in psoriatic arthritis.

Authors:  Jirí Stolfa; Markéta Fojtíková; Pavlína Cejková; Marie Cerná; Liliana Sedová; Ctibor Dostál
Journal:  Rheumatol Int       Date:  2007-06-13       Impact factor: 2.631

3.  HLA-Cw*06 class I region rather than MICA is associated with psoriatic arthritis in Czech population.

Authors:  Markéta Fojtíková; Jirí Stolfa; Peter Novota; Pavlína Cejková; Ctibor Dostál; Marie Cerná
Journal:  Rheumatol Int       Date:  2009-01-28       Impact factor: 2.631

4.  Tumour necrosis factor alpha, interferon gamma and substance P are novel modulators of extrapituitary prolactin expression in human skin.

Authors:  Ewan A Langan; Silvia Vidali; Natascha Pigat; Wolfgang Funk; Erika Lisztes; Tamás Bíró; Vincent Goffin; Christopher E M Griffiths; Ralf Paus
Journal:  PLoS One       Date:  2013-04-23       Impact factor: 3.240

Review 5.  Insight into the Endocrine System and the Immune System: A Review of the Inflammatory Role of Prolactin in Rheumatoid Arthritis and Psoriatic Arthritis.

Authors:  Man W Tang; Samuel Garcia; Danielle M Gerlag; Paul P Tak; Kris A Reedquist
Journal:  Front Immunol       Date:  2017-06-23       Impact factor: 7.561

6.  Follicular-Stimulating Hormone, Luteinizing Hormone, and Prolactin Serum Level in Patients with Oral Lichen Planus in Comparison to Healthy Population.

Authors:  Fatemeh Lavaee; Nazila Bazrafkan; Fateme Zarei; Maryam Shahrokhi Sardo
Journal:  Biomed Res Int       Date:  2021-10-26       Impact factor: 3.411

7.  Identifying disease-specific genes based on their topological significance in protein networks.

Authors:  Zoltán Dezso; Yuri Nikolsky; Tatiana Nikolskaya; Jeremy Miller; David Cherba; Craig Webb; Andrej Bugrim
Journal:  BMC Syst Biol       Date:  2009-03-23

8.  Serum prolactin levels in psoriasis vulgaris.

Authors:  Farhad Handjani; Nasrin Saki; Iman Ahrari; Mehdi Ebrahimi; Mohammad Mehdi Khorrami; Parastoo Nematollahi
Journal:  ISRN Dermatol       Date:  2014-02-23

9.  Association of psoriasis severity with serum prolactin, thyroid hormones, and cortisol before and after treatment.

Authors:  Reza M Robati; Parviz Toossi; Mohammad Rahmati-Roodsari; Sara Khalilazar; Ehsan Abolhasani; Nastaran Namazi; Shima Younespour
Journal:  ScientificWorldJournal       Date:  2013-10-28

10.  Serum prolactin levels in psoriasis and its association with disease activity: a case-control study.

Authors:  Mohammad Abid Keen; Iffat Hassan
Journal:  Indian J Dermatol       Date:  2014-11       Impact factor: 1.494

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.